![Dong Xu Qiu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dong Xu Qiu
Gründer bei
CANSINO BIOLOGICS INC.
Vermögen: 89 Mio $ am 31.05.2026
Profil
Dong Xu Qiu gründete CanSino Biologics, Inc. Er ist Mitglied des Vorstands von CanSino Biologics, Inc. und Senior Advisor bei ChinaBio LLC. Dr. Qiu promovierte an der Universität Peking, erwarb einen MBA an der University of Western Ontario, einen Bachelor-Abschluss an der Shenyang Pharmaceutical University, einen Doktortitel an der Universität Konstanz und einen Doktortitel an der University of Montral.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.12.2024 | 6’030’683 ( 9.03% ) | 52 Mio $ | 31.05.2026 | |
| 31.12.2024 | 11’083’517 ( 8.35% ) | 37 Mio $ | 31.05.2026 |
Aktive Positionen von Dong Xu Qiu
| Unternehmen | Position | Beginn |
|---|---|---|
| CANSINO BIOLOGICS INC. | Gründer | 13.01.2009 |
Suzhou GenePharma Co., Ltd.
 Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Offers core technologies of siRNA chemical synthesis, RNA monomer synthesis, custom and chemically-modified siRNA oligo synthesis, nucleic acid fluorescent labeling, and many nucleotide chemical modification technologies | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Dong Xu Qiu
| Unternehmen | Position | Ende |
|---|---|---|
ChinaBio LLC
 ChinaBio LLC Financial ConglomeratesFinance Operates as an investment, consulting and media company which helps life science companies | Corporate Officer/Principal | 01.04.2011 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Dong Xu Qiu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Health Technology |
ChinaBio LLC
ChinaBio LLC Financial ConglomeratesFinance Operates as an investment, consulting and media company which helps life science companies | Finance |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universität Konstanz
 Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
 Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CanSino Biologics, Inc.
 CanSino Biologics, Inc. BiotechnologyHealth Technology Manufactures and commercializes vaccines | Health Technology |
Suzhou GenePharma Co., Ltd.
Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Offers core technologies of siRNA chemical synthesis, RNA monomer synthesis, custom and chemically-modified siRNA oligo synthesis, nucleic acid fluorescent labeling, and many nucleotide chemical modification technologies | Health Technology |
